FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression
January 24, 2022
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted expedited approval of a supplemental new drug application (sNDA) for Veklury® (remdesivir) for the treatment of non-hospitalized adult and ...
chat_bubble0 Comment
visibility106 Views
England to Return to Plan A Following the Success of the Booster Programme
January 21, 2022
The government has today announced that England will fully return to Plan A on Thursday 27 January thanks to the success of the booster programme, with ministers urging anyone who has still not had a ...
chat_bubble0 Comment
visibility53 Views
LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant
January 14, 2022
LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that results from ongoing testing and monitoring of COVID-19 variants show its SARS-CoV-2 Antigen test detects the Omicron Variant. In-house wet testing with live ...
chat_bubble0 Comment
visibility67 Views
Popular Posts
